ADVANCED ENZYME TECHNOLOGIES
|
The Current P/S Ratio of ADVANCED ENZYME TECHNOLOGIES is 4.93.
Share Price | ₹276.3 | Mar 11,2025 |
Market Cap | ₹3,091.8 Cr | |
Sales-TTM | ₹627.5 Cr | TTM-Consolidated Results |
Price/Sales | 4.93x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of ADVANCED ENZYME TECHNOLOGIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹3,091.8 Cr] as on Mar 11,2025
(/) Sales [ ₹627.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.93x ]
Thus, for ADVANCED ENZYME TECHNOLOGIES , the investors are currently willing to pay '4.93 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ADVANCED ENZYME TECHNOLOGIES !
The chart below summarizes the trend in P/S Ratio of ADVANCED ENZYME TECHNOLOGIES over the last five years.
Historical PS (Price/Sales) ratio chart of ADVANCED ENZYME TECHNOLOGIES
PS Ratio Performance Analysis for ADVANCED ENZYME TECHNOLOGIES
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.65x.
- ADVANCED ENZYME TECHNOLOGIES 's operated at median p/e ratio of 5.96x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ADVANCED ENZYME TECHNOLOGIES 's p/e ratio peaked in Mar2021 at 7.68x.
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio hit its five-year low in Mar2020 of 3.6x.
How does ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
ADVANCED ENZYME TECHNOLOGIES | 627.5 | 4.93 | 3,091.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 7.70 | 397,246.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 16.21 | 147,119.0 |
CIPLA LTD | 26,981.2 | 4.33 | 116,805.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.16 | 103,554.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 2.98 | 93,192.0 |
MANKIND PHARMA LTD | 11,641.0 | 7.83 | 91,196.4 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.07 | 90,551.0 |
LUPIN LTD | 22,001.6 | 4.10 | 90,226.2 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.05 | 63,368.4 |
ABBOTT INDIA LTD | 6,243.2 | 10.38 | 64,826.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.05x |
Max industry PS | 16.21x |
Median industry PS | 4.93x |
Average industry PS | 6.70x |
You may also like the below Video Courses